It will state the total peptide content in milligrams
Originally engineered at Washington State University by the Harding lab and later licensed to M3 Biotechnology, Dihexa retains the angiotensin IV pharmacophore for AT4 receptor binding while incorporating N-hexanoyl and aminohexanoic acid modifications that confer metabolic stability and lipophilic BBB penetration
PubMed Ho, E.N., Kwok, W.H., Lau, M.Y., Wong, A.S., Wan, T.S., Lam, K.K., Schiff, P.J., Morishima, M., & Wong, C.H
For acute tendon or ligament injuries, typical anecdotal protocols suggest 250mcg to 500mcg twice daily, often administered near the site of injury for localized effect, though systemic routes are also used
Learn the symptoms, causes, diet, and treatment approach